Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02143999
What this trial is testing

An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 403
Not applicableStudy completedNCT06251934
What this trial is testing

Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With BRAF-Positive Metastatic Melanoma

Who this might be right for
BRAF-positive Metastatic Melanoma
Novartis Pharmaceuticals 785
Testing effectiveness (Phase 2)Study completedNCT00012064
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

Who this might be right for
Melanoma (Skin)
Lisata Therapeutics, Inc. 56
Very early researchStudy completedNCT03276832
What this trial is testing

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Who this might be right for
Metastatic MelanomaStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7+1 more
Mayo Clinic 7
Large-scale testing (Phase 3)Study completedNCT02278887
What this trial is testing

Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
The Netherlands Cancer Institute 168
Early research (Phase 1)Ended earlyNCT04967196
What this trial is testing

Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+1 more
Mayo Clinic 6
Early research (Phase 1)Study completedNCT02117362
What this trial is testing

Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Providence Health & Services 8
Testing effectiveness (Phase 2)Ended earlyNCT00509496
What this trial is testing

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes

Who this might be right for
Skin CancerMelanoma
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT01209299
What this trial is testing

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 80
Testing effectiveness (Phase 2)Study completedNCT01253564
What this trial is testing

RO5185426 in Previously Treated Melanoma Patients With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Ended earlyNCT00735332
What this trial is testing

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

Who this might be right for
Melanoma
Thallion Pharmaceuticals 49
Testing effectiveness (Phase 2)Study completedNCT00005875
What this trial is testing

Nitrocamptothecin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)UnknownNCT00002817
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 30
Testing effectiveness (Phase 2)Ended earlyNCT03724968
What this trial is testing

Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression

Who this might be right for
Metastatic MelanomaAdvanced MelanomaMetastatic Melanoma Stratified by MHC-II Expression
Elizabeth Davis 2
Testing effectiveness (Phase 2)Looking for participantsNCT06767306
What this trial is testing

Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma

Who this might be right for
Melanoma Metastatic
Melanoma Institute Australia 129
Very early researchNot Yet RecruitingNCT07700121
What this trial is testing

PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)WithdrawnNCT04042506
What this trial is testing

SBRT as a Vaccination for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)UnknownNCT00002845
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Blumenthal Cancer Center at Carolinas Medical Center 20
Not applicableNo Longer AvailableNCT01728051
What this trial is testing

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Who this might be right for
Metastatic Liver CancerOcular MelanomaCutaneous Melanoma
Delcath Systems Inc.
Early research (Phase 1)Study completedNCT00438984
What this trial is testing

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 11
Next Page